5 completed, 5 unknown, 1 active not recruiting, 1 terminated. 11 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 5, Unknown 5, Terminated 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Overseas Pharmaceuticals, Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions Pirfenidone Modified-Release Tablets - Idiopathic Pulmonary Fibrosis | Phase 1 | Completed | Overseas Pharmaceuticals, Ltd. | 18 | 2024-09-18 | 2025-03-20 |
| Comparative Pharmacokinetic Study of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Healthy Subjects Test product (T): Ramelteon Modified-Release Tablets, Reference product (R): Ramelteon Tablets - Chronic Insomnia Characterized | Phase 1 | Completed | Overseas Pharmaceuticals, Ltd. | 12 | 2024-06-24 | 2025-03-24 |
| Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions Pirfenidone Modified-Release Tablets, Pirfenidone Tablets - Idiopathic Pulmonary Fibrosis | Phase 1 | Completed | Overseas Pharmaceuticals, Ltd. | 12 | 2024-04-08 | 2024-09-19 |
| Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions Pirfenidone Modified-Release Tablets, Pirfenidone Tablets - Idiopathic Pulmonary Fibrosis | Phase 1 | Completed | Overseas Pharmaceuticals, Ltd. | 24 | 2023-08-25 | 2024-09-19 |
| Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®) - Pain, Insomnia | Phase 1 | Unknown | Overseas Pharmaceuticals, Ltd. | 16 | 2023-04-03 | 2023-02-15 |
| An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions. Lacosamide Tablets, Lacosamide extended release tablets - Epilepsy | Phase 1 | Unknown | Overseas Pharmaceuticals, Ltd. | 16 | 2023-04-01 | 2023-03-28 |
| An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions Amlodipine besylate tablets (trade name: Norfloxacin ®）, Amlodipine besylate controlled-release tablets - Hypertension | Phase 1 | Unknown | Overseas Pharmaceuticals, Ltd. | 16 | 2023-01-28 | 2023-01-04 |
| Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State Comparative Pharmacokinetic Study Felodipine sustained release tablets (trade name: plendil®), Felodipine Controlled Release Tablets - Hypertension | Phase 1 | Unknown | Overseas Pharmaceuticals, Ltd. | 16 | 2022-10-28 | 2023-02-01 |
| An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions. Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets 100mg, Brivaracetam sustained-release tablets 50mg - Partial Seizure | Phase 1 | Unknown | Overseas Pharmaceuticals, Ltd. | 12 | 2022-09-13 | 2023-02-01 |
| RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee Placebo, Ibuprofen modified release tablet 800 mg - Degenerative Arthritis | Phase 3 | Active not recruiting | Overseas Pharmaceuticals, Ltd. | 500 | 2021-12-10 | 2026-07-27 |
| To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Modified-Release Tablets 800 mg Ibuprofen Tablets - Chronic Pain | Phase 1 | Completed | Overseas Pharmaceuticals, Ltd. | 30 | 2020-12-24 | 2022-04-15 |
| To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers Advil Ibuprofen table 200 mg, Motrin IB Ibuprofen Tablets 200 mg, Ibuprofen CR Tablets 600 mg - Pain Control | Phase 1 | Terminated | Overseas Pharmaceuticals, Ltd. | 31 | 2017-12-11 | 2022-04-01 |
Idiopathic Pulmonary Fibrosis (3) · Epilepsy (2) · Hypertension (2) · Agnosia (1) · Chronic Pain (1) · Osteoarthritis (1) · Pain (1) · Seizures (1) · Sleep Initiation and Maintenance Disorders (1)
pirfenidone (2) · Amlodipine (1) · Diphenhydramine (1) · Ibuprofen (1) · Lacosamide (1) · Tablets (1) · brivaracetam (1)
China (10) · Taiwan (2) · United States (1)
Yu Cao, Doctor (2) · Cao Yu, Doctor (1) · Ming-Che Liu, M.D (1) · Pamela Kane (1)